PATH:NYSEUiPath, Inc. Analysis
Data as of 2026-08-02 - not real-time
$12.76
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
UiPath is trading near its short‑term moving average with bullish momentum indicated by a positive MACD histogram and an RSI that remains comfortably in the upper‑mid range, suggesting continued upside potential. The stock sits above a clear support zone and just below a resistance area that aligns with longer‑term trend lines, while valuation metrics show a price‑to‑earnings multiple well below the sector average and a discounted DCF estimate, pointing to a material undervaluation.
Recent AI‑related contract wins and the launch of a new AI‑native case management capability have refreshed investor interest, as reflected in heightened search activity and an “Extreme Greed” sentiment reading. However, the share price has experienced elevated short‑term volatility and the broader software‑infrastructure sector faces competitive pressure, which tempers the upside narrative.
Recent AI‑related contract wins and the launch of a new AI‑native case management capability have refreshed investor interest, as reflected in heightened search activity and an “Extreme Greed” sentiment reading. However, the share price has experienced elevated short‑term volatility and the broader software‑infrastructure sector faces competitive pressure, which tempers the upside narrative.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and supportive RSI indicating momentum
- Price positioned above a well‑defined support level
- Recent AI deal and product launch boosting sentiment
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap versus discounted cash‑flow estimate
- Revenue growth outpacing many peers and improving profitability
- Strong cash balance relative to modest debt
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Long‑term secular demand for automation and AI‑driven workflows
- Competitive landscape with larger players intensifying pressure
- Sustained path toward higher margins and cash‑flow generation
Key Metrics & Analysis
Financial Health
Revenue Growth17.30%
Profit Margin19.58%
P/E Ratio21.3
ROE18.18%
ROA2.37%
Debt/Equity4.36
P/B Ratio3.5
Op. Cash Flow$384.1M
Free Cash Flow$511.6M
Industry P/E32.8
Technical Analysis
TrendNeutral
RSI62.4
Support$10.16
Resistance$12.83
MA 20$11.79
MA 50$11.30
MA 200$12.79
MACDBullish
VolumeStable
Fear & Greed Index92.88
Valuation
Fair Value$28.15
Target Price$13.25
Upside/Downside3.83%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.07
Volatility58.76%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.